These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 29969654)

  • 21. Appearance of tissue transglutaminase in astrocytes in multiple sclerosis lesions: a role in cell adhesion and migration?
    van Strien ME; Drukarch B; Bol JG; van der Valk P; van Horssen J; Gerritsen WH; Breve JJ; van Dam AM
    Brain Pathol; 2011 Jan; 21(1):44-54. PubMed ID: 20731658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transglutaminase 2 protects against ischemic stroke.
    Filiano AJ; Tucholski J; Dolan PJ; Colak G; Johnson GV
    Neurobiol Dis; 2010 Sep; 39(3):334-43. PubMed ID: 20451610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transglutaminase 2 promotes PDGF-mediated activation of PDGFR/Akt1 and β-catenin signaling in vascular smooth muscle cells and supports neointima formation.
    Nurminskaya M; Beazley KE; Smith EP; Belkin AM
    J Vasc Res; 2014; 51(6):418-28. PubMed ID: 25612735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytosolic guanine nucledotide binding deficient form of transglutaminase 2 (R580a) potentiates cell death in oxygen glucose deprivation.
    Colak G; Keillor JW; Johnson GV
    PLoS One; 2011 Jan; 6(1):e16665. PubMed ID: 21304968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue transglutaminase activity is involved in the differentiation of oligodendrocyte precursor cells into myelin-forming oligodendrocytes during CNS remyelination.
    Van Strien ME; Baron W; Bakker EN; Bauer J; Bol JG; Brevé JJ; Binnekade R; Van Der Laarse WJ; Drukarch B; Van Dam AM
    Glia; 2011 Nov; 59(11):1622-34. PubMed ID: 21818782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells.
    Soluri MF; Boccafoschi F; Cotella D; Moro L; Forestieri G; Autiero I; Cavallo L; Oliva R; Griffin M; Wang Z; Santoro C; Sblattero D
    FASEB J; 2019 Feb; 33(2):2327-2342. PubMed ID: 30285580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transglutaminase 2 strongly binds to an extracellular matrix component other than fibronectin via its second C-terminal beta-barrel domain.
    Stamnaes J; Cardoso I; Iversen R; Sollid LM
    FEBS J; 2016 Nov; 283(21):3994-4010. PubMed ID: 27685605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Injury-induced "switch" from GTP-regulated to novel GTP-independent isoform of tissue transglutaminase in the rat spinal cord.
    Festoff BW; SantaCruz K; Arnold PM; Sebastian CT; Davies PJ; Citron BA
    J Neurochem; 2002 May; 81(4):708-18. PubMed ID: 12065630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of HMGB1 reduces rat spinal cord astrocytic swelling and AQP4 expression after oxygen-glucose deprivation and reoxygenation via TLR4 and NF-κB signaling in an IL-6-dependent manner.
    Sun L; Li M; Ma X; Feng H; Song J; Lv C; He Y
    J Neuroinflammation; 2017 Nov; 14(1):231. PubMed ID: 29178911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intimal hyperplasia in loop-injured carotid arteries is attenuated in transglutaminase 2-null mice.
    Min SK; Min SI; Jeong EM; Cho SY; Ha J; Kim SJ; Kim IG
    J Korean Med Sci; 2014 Mar; 29(3):363-9. PubMed ID: 24616585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells.
    Johnson KA; Polewski M; Terkeltaub RA
    Circ Res; 2008 Mar; 102(5):529-37. PubMed ID: 18202319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glial scar and axonal regeneration in the CNS: lessons from GFAP and vimentin transgenic mice.
    Ribotta MG; Menet V; Privat A
    Acta Neurochir Suppl; 2004; 89():87-92. PubMed ID: 15335106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of transglutaminase 2 in A
    Vyas FS; Nelson CP; Dickenson JM
    Eur J Pharmacol; 2018 Jan; 819():144-160. PubMed ID: 29208472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor Necrosis Factor-stimulated Gene-6 (TSG-6) Is Constitutively Expressed in Adult Central Nervous System (CNS) and Associated with Astrocyte-mediated Glial Scar Formation following Spinal Cord Injury.
    Coulson-Thomas VJ; Lauer ME; Soleman S; Zhao C; Hascall VC; Day AJ; Fawcett JW
    J Biol Chem; 2016 Sep; 291(38):19939-52. PubMed ID: 27435674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of neural cell adhesion molecule deletion on regeneration after mouse spinal cord injury.
    Saini V; Loers G; Kaur G; Schachner M; Jakovcevski I
    Eur J Neurosci; 2016 Jul; 44(1):1734-46. PubMed ID: 27178448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transglutaminase Type 2 regulates the Wnt/β-catenin pathway in vertebrates.
    Rossin F; Costa R; Bordi M; D'Eletto M; Occhigrossi L; Farrace MG; Barlev N; Ciccosanti F; Muccioli S; Chieregato L; Szabo I; Fimia GM; Piacentini M; Leanza L
    Cell Death Dis; 2021 Mar; 12(3):249. PubMed ID: 33674551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells.
    Jang GY; Jeon JH; Cho SY; Shin DM; Kim CW; Jeong EM; Bae HC; Kim TW; Lee SH; Choi Y; Lee DS; Park SC; Kim IG
    Oncogene; 2010 Jan; 29(3):356-67. PubMed ID: 19838207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracellular localization and conformational state of transglutaminase 2: implications for cell death.
    Gundemir S; Johnson GV
    PLoS One; 2009 Jul; 4(7):e6123. PubMed ID: 19568436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transglutaminase 2 as a therapeutic target for neurological conditions.
    Keillor JW; Johnson GVW
    Expert Opin Ther Targets; 2021 Sep; 25(9):721-731. PubMed ID: 34607527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CHIP-mediated degradation of transglutaminase 2 negatively regulates tumor growth and angiogenesis in renal cancer.
    Min B; Park H; Lee S; Li Y; Choi JM; Lee JY; Kim J; Choi YD; Kwon YG; Lee HW; Bae SC; Yun CO; Chung KC
    Oncogene; 2016 Jul; 35(28):3718-28. PubMed ID: 26568304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.